Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Amyloid beta-Peptides (2)
- Humans (2)
- Tau Proteins (2)
- 4-hydroxy-2-nonenal (1)
- Aged (1)
-
- Aged, 80 and over (1)
- Aging (1)
- Aldehydes (1)
- Alzheimer Disease (1)
- Alzheimer’s Disease (1)
- Biomarkers (1)
- Clusterin (1)
- Databases, Factual (1)
- Dementia (1)
- Down Syndrome (1)
- Female (1)
- GPI-Linked Proteins (1)
- Genetic Predisposition to Disease (1)
- Genetics (1)
- Genome-Wide Association Study (1)
- Glucose (1)
- Granulin (1)
- Hippocampus (1)
- Intercellular Signaling Peptides and Proteins (1)
- Lipid Peroxidation (1)
- Lipid peroxidation (1)
- Male (1)
- Mitochondria (1)
- Neurofibrillary Tangles (1)
- Neuroinflammation (1)
Articles 1 - 3 of 3
Full-Text Articles in Genetics and Genomics
Editorial For The Genetics Of Alzheimer’S Disease Special Issue: October 2021, Laura Ibanez, Justin B. Miller
Editorial For The Genetics Of Alzheimer’S Disease Special Issue: October 2021, Laura Ibanez, Justin B. Miller
Sanders-Brown Center on Aging Faculty Publications
No abstract provided.
Hne-Modified Proteins In Down Syndrome: Involvement In Development Of Alzheimer Disease Neuropathology, Eugenio Barone, Elizabeth Head, D. Allan Butterfield, Marzia Perluigi
Hne-Modified Proteins In Down Syndrome: Involvement In Development Of Alzheimer Disease Neuropathology, Eugenio Barone, Elizabeth Head, D. Allan Butterfield, Marzia Perluigi
Sanders-Brown Center on Aging Faculty Publications
Down syndrome (DS), trisomy of chromosome 21, is the most common genetic form of intellectual disability. The neuropathology of DS involves multiple molecular mechanisms, similar to AD, including the deposition of beta-amyloid (Aβ) into senile plaques and tau hyperphosphorylating in neurofibrillary tangles. Interestingly, many genes encoded by chromosome 21, in addition to being primarily linked to amyloid-beta peptide (Aβ) pathology, are responsible for increased oxidative stress (OS) conditions that also result as a consequence of reduced antioxidant system efficiency. However, redox homeostasis is disturbed by overproduction of Aβ, which accumulates into plaques across the lifespan in DS as well as …
Csf Protein Changes Associated With Hippocampal Sclerosis Risk Gene Variants Highlight Impact Of Grn/Pgrn, David W. Fardo, Yuriko Katsumata, John S. K. Kauwe, Yuetiva Deming, Oscar Harari, Carlos Cruchaga, Alzheimer’S Disease Neuroimaging Initiative, Peter T. Nelson
Csf Protein Changes Associated With Hippocampal Sclerosis Risk Gene Variants Highlight Impact Of Grn/Pgrn, David W. Fardo, Yuriko Katsumata, John S. K. Kauwe, Yuetiva Deming, Oscar Harari, Carlos Cruchaga, Alzheimer’S Disease Neuroimaging Initiative, Peter T. Nelson
Sanders-Brown Center on Aging Faculty Publications
Objective—Hippocampal sclerosis of aging (HS-Aging) is a common cause of dementia in older adults. We tested the variability in cerebrospinal fluid (CSF) proteins associated with previously identified HS-Aging risk single nucleotide polymorphisms (SNPs).
Methods—Alzheimer’s Disease Neuroimaging Initiative cohort (ADNI; n=237) data, combining both multiplexed proteomics CSF and genotype data, were used to assess the association between CSF analytes and risk SNPs in four genes (SNPs): GRN (rs5848), TMEM106B (rs1990622), ABCC9 (rs704180), and KCNMB2 (rs9637454). For controls, non-HS-Aging SNPs in APOE (rs429358/rs7412) and MAPT (rs8070723) were also analyzed against Aβ1-42 and total tau CSF analytes.
Results—The GRN risk …